These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 12738738)

  • 1. Gain of chromosome 8q23-24 is a predictive marker for lymph node positivity in colorectal cancer.
    Ghadimi BM; Grade M; Liersch T; Langer C; Siemer A; Füzesi L; Becker H
    Clin Cancer Res; 2003 May; 9(5):1808-14. PubMed ID: 12738738
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metastatic potential in T1 and T2 colorectal cancer.
    Fang WL; Chang SC; Lin JK; Wang HS; Yang SH; Jiang JK; Chen WC; Lin TC
    Hepatogastroenterology; 2005; 52(66):1688-91. PubMed ID: 16334758
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Interphase cytogenetics of prostatic tumor progression: specific chromosomal abnormalities are involved in metastasis to the bone.
    Alers JC; Krijtenburg PJ; Rosenberg C; Hop WC; Verkerk AM; Schröder FH; van der Kwast TH; Bosman FT; van Dekken H
    Lab Invest; 1997 Nov; 77(5):437-48. PubMed ID: 9389787
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chromosomal aberrations detected by comparative genomic hybridization predict outcome in patients with colorectal carcinoma.
    Liu XP; Kawauchi S; Oga A; Sato T; Ikemoto K; Ikeda E; Sasaki K
    Oncol Rep; 2007 Jan; 17(1):261-7. PubMed ID: 17143507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor budding as an indicator of isolated tumor cells in lymph nodes from patients with node-negative colorectal cancer.
    Park SY; Choe G; Lee HS; Jung SY; Park JG; Kim WH
    Dis Colon Rectum; 2005 Feb; 48(2):292-302. PubMed ID: 15616755
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Loss of p53 and c-myc overrepresentation in stage T(2-3)N(1-3)M(0) prostate cancer are potential markers for cancer progression.
    Qian J; Hirasawa K; Bostwick DG; Bergstralh EJ; Slezak JM; Anderl KL; Borell TJ; Lieber MM; Jenkins RB
    Mod Pathol; 2002 Jan; 15(1):35-44. PubMed ID: 11796839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stage III colorectal cancer: molecular disparity between primary cancers and lymph node metastases.
    Messick CA; Church JM; Liu X; Ting AH; Kalady MF
    Ann Surg Oncol; 2010 Feb; 17(2):425-31. PubMed ID: 19885699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Genomic alterations in primary breast cancers compared with their sentinel and more distal lymph node metastases: an aCGH study.
    Wang C; Iakovlev VV; Wong V; Leung S; Warren K; Iakovleva G; Arneson NC; Pintilie M; Miller N; Youngson B; McCready DR; Done SJ
    Genes Chromosomes Cancer; 2009 Dec; 48(12):1091-101. PubMed ID: 19760610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of nodal metastasis by comparative genomic hybridization in biopsy specimens from patients with superficial esophageal squamous cell carcinoma.
    Ueno T; Tangoku A; Yoshino S; Abe T; Hayashi H; Toshimitsu H; Hashimoto K; Satoh T; Oga A; Furuya T; Oka M; Sasaki K
    Clin Cancer Res; 2003 Nov; 9(14):5137-41. PubMed ID: 14613991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular genetic changes in metastatic primary Barrett's adenocarcinoma and related lymph node metastases: comparison with nonmetastatic Barrett's adenocarcinoma.
    Walch AK; Zitzelsberger HF; Bink K; Hutzler P; Bruch J; Braselmann H; Aubele MM; Mueller J; Stein H; Siewert JR; Höfler H; Werner M
    Mod Pathol; 2000 Jul; 13(7):814-24. PubMed ID: 10912943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In lymph node-negative invasive breast carcinomas, specific chromosomal aberrations are strongly associated with high mitotic activity and predict outcome more accurately than grade, tumour diameter, and oestrogen receptor.
    Janssen EA; Baak JP; Guervós MA; van Diest PJ; Jiwa M; Hermsen MA
    J Pathol; 2003 Dec; 201(4):555-61. PubMed ID: 14648658
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Genomic changes in primary lesion and lymph node metastases of esophageal squamous cell carcinoma].
    Qin YR; Wang LD; Dora K; Guan XY; Zhuang ZH; Fan ZM; Deng W; Cao SH
    Ai Zheng; 2005 Sep; 24(9):1048-53. PubMed ID: 16159423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic changes and clonality relationship between primary colorectal cancers and their pulmonary metastases--an analysis by comparative genomic hybridization.
    Jiang JK; Chen YJ; Lin CH; Yu IT; Lin JK
    Genes Chromosomes Cancer; 2005 May; 43(1):25-36. PubMed ID: 15723340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinicopathologic significance of chromosomal DNA sequence copy number aberrations in patients with colorectal carcinoma].
    Liu XP; Kawauchi S; Oga A; Sasaki K
    Zhonghua Zhong Liu Za Zhi; 2007 May; 29(5):355-9. PubMed ID: 17892131
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of angiogenesis markers with lymph node metastasis in early colorectal cancer.
    Iddings DM; Koda EA; Grewal SS; Parker R; Saha S; Bilchik A
    Arch Surg; 2007 Aug; 142(8):738-44; discussion 744-5. PubMed ID: 17709727
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DNA sequence losses on chromosomes 11p and 18q are associated with clinical outcome in lymph node-negative ductal breast cancer.
    Dellas A; Torhorst J; Schultheiss E; Mihatsch MJ; Moch H
    Clin Cancer Res; 2002 May; 8(5):1210-6. PubMed ID: 12006540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multimarker phenotype predicts adverse survival in patients with lymph node-negative colorectal cancer.
    Zlobec I; Minoo P; Baumhoer D; Baker K; Terracciano L; Jass JR; Lugli A
    Cancer; 2008 Feb; 112(3):495-502. PubMed ID: 18076013
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genomic alterations associated with early stages of breast tumor metastasis.
    Ellsworth RE; Ellsworth DL; Patney HL; Deyarmin B; Hooke JA; Love B; Shriver CD
    Ann Surg Oncol; 2008 Jul; 15(7):1989-95. PubMed ID: 18401664
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High epidermal growth factor receptor expression in metastatic colorectal cancer lymph nodes may be more prognostic of poor survival than in primary tumor.
    Deng Y; Kurland BF; Wang J; Bi J; Li W; Rao S; Lan P; Lin T; Lin E
    Am J Clin Oncol; 2009 Jun; 32(3):245-52. PubMed ID: 19451802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk factors for occult lymph node metastasis of colorectal cancer invading the submucosa and indications for endoscopic mucosal resection.
    Yasuda K; Inomata M; Shiromizu A; Shiraishi N; Higashi H; Kitano S
    Dis Colon Rectum; 2007 Sep; 50(9):1370-6. PubMed ID: 17661146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.